EUVIMEDEUVIMED entdecken
Crossref

Intellectual Property and Vaccine Manufacturing: Utilizing Existing TRIPS Agreement Flexibilities for COVID-19 and Other Public Health Crises

Andrew Mitchell, Antony Taubman, Theodore Samlidis

Tulane Journal of Technology & Intellectual Property · 21.02.2024 · 25

DOI: 10.37381/43nsz093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tulane Journal of Technology & Intellectual Property, online erschienen am 21.02.2024. Verfasst von Andrew Mitchell und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mitchell, A., Taubman, A., & Samlidis, T. (2024). Intellectual Property and Vaccine Manufacturing: Utilizing Existing TRIPS Agreement Flexibilities for COVID-19 and Other Public Health Crises. Tulane Journal of Technology & Intellectual Property, 25. https://doi.org/10.37381/43nsz093

Vancouver

Mitchell A, Taubman A, Samlidis T. Intellectual Property and Vaccine Manufacturing: Utilizing Existing TRIPS Agreement Flexibilities for COVID-19 and Other Public Health Crises. Tulane Journal of Technology & Intellectual Property. 2024;25. doi:10.37381/43nsz093

BibTeX
@article{Mitchell2024,
  author = {Mitchell, Andrew and Taubman, Antony and Samlidis, Theodore},
  title = {Intellectual Property and Vaccine Manufacturing: Utilizing Existing TRIPS Agreement Flexibilities for COVID-19 and Other Public Health Crises},
  journal = {Tulane Journal of Technology & Intellectual Property},
  year = {2024},
  volume = {25},
  doi = {10.37381/43nsz093}
}
Kostenlos starten →